Skip to main content
. 2023 Oct 17;15(10):2483. doi: 10.3390/pharmaceutics15102483

Figure 2.

Figure 2

MSN-based active-targeting delivery and responsive release of siRNA for cancer RNA interference (RNAi) therapeutics.